Report Detail

Pharma & Healthcare Global (United States, European Union and China) Oral Vaccine Market Research Report 2019-2025

  • RnM3715167
  • |
  • 02 September, 2019
  • |
  • Global
  • |
  • 129 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Oral vaccines are safe and easy to administer and convenient for all ages. They have been successfully developed to protect from many infectious diseases acquired through oral transmission. Oral delivery of vaccines represents the most attractive mode of administration over other routes of delivery due to the fact that the oral vaccination is noninvasive, safe and simple to execute, showing good patient compliance and clinical practicality.
In 2019, the market size of Oral Vaccine is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Oral Vaccine.

This report studies the global market size of Oral Vaccine, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Oral Vaccine sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
Merck
GSK
Sanofi
Lanzhou Institute
Serum Institute
Valneva
Shanghai United Cell
Bibcol
PaxVax
Vabiotech
Tiantan Biological
EuBiologics
Panacea Biotec Ltd
Bio-Med
Halfkin Bio-Pharmaceuticals

Market Segment by Product Type
Rotavirus Vaccine
Cholera Vaccine
Oral Polio Vaccine
Others

Market Segment by Application
Public
Private

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Oral Vaccine status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Oral Vaccine manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Oral Vaccine are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025


Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Oral Vaccine Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 Rotavirus Vaccine
      • 1.3.3 Cholera Vaccine
      • 1.3.4 Oral Polio Vaccine
      • 1.3.5 Others
    • 1.4 Market Segment by Application
      • 1.4.1 Global Oral Vaccine Market Share by Application (2019-2025)
      • 1.4.2 Public
      • 1.4.3 Private
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Global Oral Vaccine Market Size
      • 2.1.1 Global Oral Vaccine Revenue 2014-2025
      • 2.1.2 Global Oral Vaccine Sales 2014-2025
    • 2.2 Oral Vaccine Growth Rate by Regions
      • 2.2.1 Global Oral Vaccine Sales by Regions 2014-2019
      • 2.2.2 Global Oral Vaccine Revenue by Regions 2014-2019
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Oral Vaccine Sales by Manufacturers
      • 3.1.1 Oral Vaccine Sales by Manufacturers 2014-2019
      • 3.1.2 Oral Vaccine Sales Market Share by Manufacturers 2014-2019
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Oral Vaccine Revenue by Manufacturers (2014-2019)
      • 3.2.2 Oral Vaccine Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Oral Vaccine Market Concentration Ratio (CR5 and HHI)
    • 3.3 Oral Vaccine Price by Manufacturers
    • 3.4 Key Manufacturers Oral Vaccine Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Oral Vaccine Market
    • 3.6 Key Manufacturers Oral Vaccine Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Sales and Revenue for Each Type
      • 4.1.1 Rotavirus Vaccine Sales and Revenue (2014-2019)
      • 4.1.2 Cholera Vaccine Sales and Revenue (2014-2019)
      • 4.1.3 Oral Polio Vaccine Sales and Revenue (2014-2019)
      • 4.1.4 Others Sales and Revenue (2014-2019)
    • 4.2 Global Oral Vaccine Sales Market Share by Type
    • 4.3 Global Oral Vaccine Revenue Market Share by Type
    • 4.4 Oral Vaccine Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Oral Vaccine Sales by Application

    6 United States

    • 6.1 United States Oral Vaccine Breakdown Data by Company
    • 6.2 United States Oral Vaccine Breakdown Data by Type
    • 6.3 United States Oral Vaccine Breakdown Data by Application

    7 European Union

    • 7.1 European Union Oral Vaccine Breakdown Data by Company
    • 7.2 European Union Oral Vaccine Breakdown Data by Type
    • 7.3 European Union Oral Vaccine Breakdown Data by Application

    8 China

    • 8.1 China Oral Vaccine Breakdown Data by Company
    • 8.2 China Oral Vaccine Breakdown Data by Type
    • 8.3 China Oral Vaccine Breakdown Data by Application

    9 Rest of World

    • 9.1 Rest of World Oral Vaccine Breakdown Data by Company
    • 9.2 Rest of World Oral Vaccine Breakdown Data by Type
    • 9.3 Rest of World Oral Vaccine Breakdown Data by Application
    • 9.4 Rest of World Oral Vaccine Breakdown Data by Countries
      • 9.4.1 Rest of World Oral Vaccine Sales by Countries
      • 9.4.2 Rest of World Oral Vaccine Revenue by Countries
      • 9.4.3 Japan
      • 9.4.4 Korea
      • 9.4.5 India
      • 9.4.6 Southeast Asia

    10 Company Profiles

    • 10.1 Merck
      • 10.1.1 Merck Company Details
      • 10.1.2 Company Description and Business Overview
      • 10.1.3 Sales, Revenue and Market Share of Oral Vaccine
      • 10.1.4 Oral Vaccine Product Introduction
      • 10.1.5 Merck Recent Development
    • 10.2 GSK
      • 10.2.1 GSK Company Details
      • 10.2.2 Company Description and Business Overview
      • 10.2.3 Sales, Revenue and Market Share of Oral Vaccine
      • 10.2.4 Oral Vaccine Product Introduction
      • 10.2.5 GSK Recent Development
    • 10.3 Sanofi
      • 10.3.1 Sanofi Company Details
      • 10.3.2 Company Description and Business Overview
      • 10.3.3 Sales, Revenue and Market Share of Oral Vaccine
      • 10.3.4 Oral Vaccine Product Introduction
      • 10.3.5 Sanofi Recent Development
    • 10.4 Lanzhou Institute
      • 10.4.1 Lanzhou Institute Company Details
      • 10.4.2 Company Description and Business Overview
      • 10.4.3 Sales, Revenue and Market Share of Oral Vaccine
      • 10.4.4 Oral Vaccine Product Introduction
      • 10.4.5 Lanzhou Institute Recent Development
    • 10.5 Serum Institute
      • 10.5.1 Serum Institute Company Details
      • 10.5.2 Company Description and Business Overview
      • 10.5.3 Sales, Revenue and Market Share of Oral Vaccine
      • 10.5.4 Oral Vaccine Product Introduction
      • 10.5.5 Serum Institute Recent Development
    • 10.6 Valneva
      • 10.6.1 Valneva Company Details
      • 10.6.2 Company Description and Business Overview
      • 10.6.3 Sales, Revenue and Market Share of Oral Vaccine
      • 10.6.4 Oral Vaccine Product Introduction
      • 10.6.5 Valneva Recent Development
    • 10.7 Shanghai United Cell
      • 10.7.1 Shanghai United Cell Company Details
      • 10.7.2 Company Description and Business Overview
      • 10.7.3 Sales, Revenue and Market Share of Oral Vaccine
      • 10.7.4 Oral Vaccine Product Introduction
      • 10.7.5 Shanghai United Cell Recent Development
    • 10.8 Bibcol
      • 10.8.1 Bibcol Company Details
      • 10.8.2 Company Description and Business Overview
      • 10.8.3 Sales, Revenue and Market Share of Oral Vaccine
      • 10.8.4 Oral Vaccine Product Introduction
      • 10.8.5 Bibcol Recent Development
    • 10.9 PaxVax
      • 10.9.1 PaxVax Company Details
      • 10.9.2 Company Description and Business Overview
      • 10.9.3 Sales, Revenue and Market Share of Oral Vaccine
      • 10.9.4 Oral Vaccine Product Introduction
      • 10.9.5 PaxVax Recent Development
    • 10.10 Vabiotech
      • 10.10.1 Vabiotech Company Details
      • 10.10.2 Company Description and Business Overview
      • 10.10.3 Sales, Revenue and Market Share of Oral Vaccine
      • 10.10.4 Oral Vaccine Product Introduction
      • 10.10.5 Vabiotech Recent Development
    • 10.11 Tiantan Biological
    • 10.12 EuBiologics
    • 10.13 Panacea Biotec Ltd
    • 10.14 Bio-Med
    • 10.15 Halfkin Bio-Pharmaceuticals

    11 Value Chain and Sales Channels Analysis

    • 11.1 Value Chain Analysis
    • 11.2 Sales Channels Analysis
      • 11.2.1 Oral Vaccine Sales Channels
      • 11.2.2 Oral Vaccine Distributors
    • 11.3 Oral Vaccine Customers

    12 Market Forecast

    • 12.1 Global Oral Vaccine Sales and Revenue Forecast 2019-2025
    • 12.2 Global Oral Vaccine Sales Forecast by Type
    • 12.3 Global Oral Vaccine Sales Forecast by Application
    • 12.4 Oral Vaccine Forecast by Regions
      • 12.4.1 Global Oral Vaccine Sales Forecast by Regions 2019-2025
      • 12.4.2 Global Oral Vaccine Revenue Forecast by Regions 2019-2025
    • 12.5 United States Market Forecast
    • 12.6 European Union Market Forecast
    • 12.7 China Market Forecast
    • 12.8 Rest of World
      • 12.8.1 Japan
      • 12.8.2 Korea
      • 12.8.3 India

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Research Methodology
        • 14.1.1 Methodology/Research Approach
          • 14.1.1.1 Research Programs/Design
          • 14.1.1.2 Market Size Estimation
          • 14.1.1.3 Market Breakdown and Data Triangulation
        • 14.1.2 Data Source
          • 14.1.2.1 Secondary Sources
          • 14.1.2.2 Primary Sources
      • 14.2 Author Details

      Summary:
      Get latest Market Research Reports on Oral Vaccine. Industry analysis & Market Report on Oral Vaccine is a syndicated market report, published as Global (United States, European Union and China) Oral Vaccine Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Oral Vaccine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,280.00
      $4,920.00
      $6,560.00
      2,584.64
      3,876.96
      5,169.28
      3,017.60
      4,526.40
      6,035.20
      510,368.00
      765,552.00
      1,020,736.00
      273,486.40
      410,229.60
      546,972.80
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report